Clinical Trials on Skin Carcinoma

Total 71342 results

Novartis Pharmaceuticals

Terminated

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)

Sporadic Superficial and Nodular Skin Basal Cell Carcinomas

Austria, Australia
University Hospital, Bordeaux
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions (MITOSKIN)

Basal Cell Carcinomas | Cutaneous Squamous Cell Carcinoma

France
University Hospital, Strasbourg, France

Unknown

MRI in Ductal Carcinoma in Situ (DCIS)

Ductal Carcinomas

France
UCSF Benioff Children's Hospital Oakland

Completed

Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer (NPEF)

Basal Cell Carcinomas

United States
Maastricht University Medical Center

Recruiting

Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region

Quality of Life | Satisfaction, Patient | Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of Head and Neck | Skin Cancer | Squamous Cell Carcinomas | Squamous Cell Carcinoma of the Skin | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell Carcinoma | High-Risk Cancer

Netherlands
Elucid Labs Inc.

Unknown

Elucid Labs AIDA™ - Labelled Image Acquisition Protocol

Melanoma (Skin) | Squamous Cell Carcinoma of the Skin | Basal Cell Carcinoma of the Skin

Canada
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Skin Cancer | Squamous Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Locally Advanced Skin Squamous Cell Carcinoma | Locally Advanced Cutaneous Squamous Cell Carcinoma | Locally Advanced Squamous Cell Carcinoma | Locally Advanced Squamous Cell Carcinoma of the Skin

United States
Salzburger Landeskliniken
Bristol-Myers Squibb

Recruiting

Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin

Squamous Cell Carcinoma of the Skin

Austria
National Cancer Institute (NCI)

Completed

S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Recurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin

United States
National Cancer Institute (NCI)

Completed

Oblimersen in Treating Patients With Merkel Cell Carcinoma

Recurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage IV Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin | Stage I Neuroendocrine Carcinoma of the Skin

United States
City of Hope Medical Center
National Cancer Institute (NCI); Genentech, Inc.

Recruiting

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

Locally Advanced Skin Squamous Cell Carcinoma | Unresectable Skin Squamous Cell Carcinoma | Resectable Skin Squamous Cell Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Gastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Stage... and other conditions

United States
Renee Cattell

Not yet recruiting

Raman Spectroscopy and Skin Cancer

Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma

United States
Ivan Litvinov

Terminated

Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer (MUSIC-01)

Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-melanoma Skin Cancer

Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

Skin Squamous Cell Carcinoma | Metastatic Skin Cancer

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin

Squamous Cell Carcinoma of the Skin | Recurrent Skin Cancer

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Completed

Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin

Metastatic Skin Squamous Cell Carcinoma | Recurrent Skin Squamous Cell Carcinoma | Locally Advanced Skin Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Merkel Cell Carcinoma | Neuroendocrine Carcinoma of the Skin | Trabecular Carcinoma of the Skin

United States
National Cancer Institute (NCI)

Completed

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

Actinic Keratosis | Squamous Cell Carcinoma of the Skin | Recurrent Skin Cancer | Basal Cell Carcinoma of the Skin

United States
Bispebjerg Hospital
University of Copenhagen

Active, not recruiting

Skin Tumor Biomarkers by Mass Spectrometry Imaging

Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-melanoma Skin Cancer

Denmark
University of Southern California
National Cancer Institute (NCI)

Recruiting

A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer

Recurrent Skin Squamous Cell Carcinoma | Resectable Skin Squamous Cell Carcinoma | Stage I Skin Cancer | Stage II Skin Cancer | Stage III Skin Cancer

United States
[Redacted]
Golden State Dermatology

Withheld

[Trial of device that is not approved or cleared by the U.S. FDA]

Skin Cancer | Skin Lesion | Skin Melanoma | Skin Cancer, Non-Melanoma | Skin Cancers - Squamous Cell Carcinoma | Skin Cancers - Basal Cell Carcinoma

United States
Emory University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...

Active, not recruiting

Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer

Recurrent Skin Carcinoma | Skin Squamous Cell Carcinoma

United States
Melanoma Institute Australia

Recruiting

A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma (SONIB)

Skin Cancer | Basal Cell Carcinoma | Invasive Carcinoma | Basal Cell Carcinoma of Skin, Site Unspecified

Australia
University of Florida

Terminated

Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma

Squamous Cell Skin Carcinoma

United States
Sung Hyun Pyun

Unknown

Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope

Skin Cancer

Australia
Massachusetts General Hospital
Nu Skin Enterprises

Completed

Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer

Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma

United States
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Completed

Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.

Melanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-Malignant Skin Disorders

United States
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH); University of Rochester

Completed

Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo

Melanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-Malignant Skin Disorders

United States
University of Western Ontario, Canada

Completed

Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples

Neuroendocrine Carcinoma (Carcinoid)

Canada
Dartmouth-Hitchcock Medical Center

Withdrawn

Same-day Versus Separate-day Preoperative Consultation for Mohs Surgery

Basal Cell Carcinoma | Non-melanoma Skin Cancer | Squamous Cell Carcinoma of Skin
Morphogenesis, Inc.

Completed

IFx-Hu2.0 for the Treatment of Patients With Skin Cancer

Basal Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

United States
Central Hospital, Nancy, France

Unknown

ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS (PADAONCODERM)

Melanoma | Skin Cancer | Oncology | Skin Squamous Cell Carcinoma | Advance Directives | Skin Lymphoma | Metastatic Basal Cell Carcinoma

France
San Diego State University

Completed

Strategies to Promote Skin Health

Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma | Skin Cancer Melanoma

United States
Sue Yom
Genentech, Inc.

Completed

Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma

Skin Cancer | Locally Advanced Basal Cell Carcinoma | Cutaneous Malignancy

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer

Pain | Recurrent Skin Cancer | Basal Cell Carcinoma of the Skin

United States
Association of Dermatological Prevention, Germany
University of Alberta; University of Calgary

Unknown

Skin Cancer Screening Education Study (SCSES)

Melanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Skin Tumors

Canada
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Completed

Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer

Squamous Cell Carcinoma of the Skin | Recurrent Skin Cancer

United States
Trakya University

Recruiting

SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity

Basal Cell Carcinoma

Turkey
Oxford University Hospitals NHS Trust
University of Oxford

Completed

Utility of the Skin Cancer Quality of Life Impact Tool (SCQOLIT)

Basal Cell Carcinoma | Squamous Cell Carcinoma | Skin Neoplasm

United Kingdom
University Hospital, Ghent

Completed

Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial

Bowen's Disease | Superficial Basal Cell Carcinoma

Belgium
Falo, Louis, MD
National Cancer Institute (NCI)

Recruiting

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) (cSCC)

Cutaneous Squamous Cell Carcinoma | Skin Cancers - Squamous Cell Carcinoma

United States
Stanford University
National Cancer Institute (NCI); University Hospitals Cleveland Medical Center

Completed

Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC)

Recurrent Skin Cancer | Basal Cell Carcinoma of the Skin

United States
Neotherix Limited
NAMSA; Innovate UK; Lorien Engineering Solutions (a division of GP Strategies... and other collaborators

Completed

EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds

Basal Cell Carcinoma | Squamous Cell Carcinoma | Non-melanoma Skin Cancer

United Kingdom
Nina Bhardwaj
Oncovir, Inc.

Terminated

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) (Hiltonol)

Melanoma | Breast Cancer | Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the Skin | Sarcoma of the Skin | Basal Cell Cancer of the Skin

United States
National Cancer Institute (NCI)

Completed

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

Squamous Cell Carcinoma of the Skin | Recurrent Skin Cancer

United States
Philogen S.p.A.

Recruiting

Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients (DUNCAN)

Carcinoma, Basal Cell | Carcinoma, Cutaneous Squamous Cell

Germany, Poland, Switzerland
Rabin Medical Center

Unknown

Molecular Characterization of Cutaneous Tumors

Basal Cell Carcinoma | Squamous Cell Carcinoma

Israel
Verrica Pharmaceuticals Inc.
Instat Clinical Research; HeartcoR Solutions; Myonex; Vial Health Technology, Inc

Recruiting

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Carcinoma | Skin Cancer | Basal Cell Carcinoma | Cancer of the Skin, Basal Cell | Cancer of the Skin

United States
Mayo Clinic

Completed

Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery

Anxiety | Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma

United States

Clinical Trials on Skin Carcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations